17 hours Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here’s What You Should KnowZacks
The consensus price target hints at a 51.1% upside potential for Amicus Therapeutics (FOLD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
X